Zithromaxsolo Trademark Details
Word Mark | Zithromaxsolo |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
235 East 42nd Street
New York, Ny 10017
Serial Number | 78432173 |
---|---|
Status Date | Tuesday, August 8, 2006 |
Filing Date | Tuesday, August 8, 2006 |
Attorney | Christopher N. Bolinger |
Correspondent
CHRISTOPHER N. BOLINGER
PFIZER INC.
150 E 42ND ST
NEW YORK NY 10017-5612
PFIZER INC.
150 E 42ND ST
NEW YORK NY 10017-5612
Case File Statements
Goods & Services | Antibiotic Preparation |
---|---|
Lining/Stippling Statement | The stippling is for shading purposes only. |
Pseudo Mark | Zithromax Solo |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Wednesday, June 16, 2004 |
Primary Code | 005 |
Trademark Timeline
-
Jun 09 2004Trademark application filed with USPTO
-
Jun 16 2004New Application Entered In Tram
-
Jul 22 2004Assigned To Examiner
-
Jul 29 2004Combined Examiner's Amendment/priority Action Entered
-
Jul 30 2004Examiner's Amendment And/or Priority Action Mailed
-
Jul 30 2004Examiner's Amendment And/or Priority Action Mailed
-
Aug 03 2004Assigned To Lie
-
Aug 26 2004Assigned To Lie
-
Jan 31 2005Correspondence Received In Law Office
-
Jan 31 2005Teas Response To Office Action Received
-
Feb 15 2005Teas/email Correspondence Entered
-
Mar 09 2005Final Refusal Written
-
Mar 28 2005Final Refusal Mailed
-
Aug 08 2005Correspondence Received In Law Office
-
Aug 08 2005Paper Received
-
Sep 21 2005Approved For Pub - Principal Register
-
Sep 21 2005Amendment From Applicant Entered
-
Sep 29 2005Law Office Publication Review Completed
-
Oct 26 2005Notice of Publication
-
Nov 15 2005Published For Opposition
-
Feb 07 2006Noa Mailed - Sou Required From Applicant
-
Oct 12 2006Abandonment Notice Mailed - No Use Statement Filed
-
Oct 12 2006Abandonment - No Use Statement Filed